AU6405790A - Preparations containing colestyramine for reducing lipid levels - Google Patents

Preparations containing colestyramine for reducing lipid levels

Info

Publication number
AU6405790A
AU6405790A AU64057/90A AU6405790A AU6405790A AU 6405790 A AU6405790 A AU 6405790A AU 64057/90 A AU64057/90 A AU 64057/90A AU 6405790 A AU6405790 A AU 6405790A AU 6405790 A AU6405790 A AU 6405790A
Authority
AU
Australia
Prior art keywords
preparations containing
lipid levels
reducing lipid
colestyramine
containing colestyramine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU64057/90A
Other versions
AU638493B2 (en
Inventor
Thomas Moest
Erwin Spiegel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordmark Arzneimittel GmbH and Co KG
Original Assignee
Nordmark Arzneimittel GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19893930206 external-priority patent/DE3930206A1/en
Priority claimed from DE3930168A external-priority patent/DE3930168A1/en
Application filed by Nordmark Arzneimittel GmbH and Co KG filed Critical Nordmark Arzneimittel GmbH and Co KG
Publication of AU6405790A publication Critical patent/AU6405790A/en
Application granted granted Critical
Publication of AU638493B2 publication Critical patent/AU638493B2/en
Assigned to NORDMARK ARZNEIMITTEL GMBH & CO KG reassignment NORDMARK ARZNEIMITTEL GMBH & CO KG Alteration of Name(s) in Register under S187 Assignors: KNOLL AKTIENGESELLSCHAFT
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Preparations containing colestyramine for reducing lipid levels.
AU64057/90A 1989-09-09 1990-09-07 Preparations containing colestyramine for reducing lipid levels Ceased AU638493B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19893930206 DE3930206A1 (en) 1989-09-09 1989-09-09 Hypolipaemic pharmaceutical prods. - comprising combination of cholestyramine and drug of vibrate type
DE3930168 1989-09-09
DE3930206 1989-09-09
DE3930168A DE3930168A1 (en) 1989-09-09 1989-09-09 Pharmaceutical compsn. contg. colestyramine to reduce lipid - in micro:tablet form levels without unpleasant taste

Publications (2)

Publication Number Publication Date
AU6405790A true AU6405790A (en) 1991-04-08
AU638493B2 AU638493B2 (en) 1993-07-01

Family

ID=25884990

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64057/90A Ceased AU638493B2 (en) 1989-09-09 1990-09-07 Preparations containing colestyramine for reducing lipid levels

Country Status (10)

Country Link
EP (1) EP0594570B1 (en)
JP (1) JPH05500213A (en)
KR (1) KR920703071A (en)
AT (1) ATE125448T1 (en)
AU (1) AU638493B2 (en)
CA (1) CA2065151A1 (en)
DE (1) DE59009451D1 (en)
DK (1) DK0594570T3 (en)
IL (1) IL95574A (en)
WO (1) WO1991003249A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG190029A1 (en) 2010-11-08 2013-06-28 Albireo Ab Ibat inhibitors for the treatment of liver diseases
WO2015199147A1 (en) 2014-06-25 2015-12-30 味の素株式会社 Solid preparation, and method for preventing or reducing discoloration thereof
EP3012252A1 (en) 2014-10-24 2016-04-27 Ferring BV Crystal modifications of elobixibat
WO2017138876A1 (en) * 2016-02-09 2017-08-17 Albireo Ab Cholestyramine pellets and methods for preparation thereof
EP3413878B1 (en) * 2016-02-09 2021-04-14 Albireo AB Oral cholestyramine formulation and use thereof
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
RU2750944C2 (en) * 2016-02-09 2021-07-06 Альбирео Аб Oral cholestyramine composition and application thereof
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
CA3071285A1 (en) 2017-08-09 2019-02-14 Albireo Ab Cholestyramine granules, oral cholestyramine formulations and use thereof
EP3664782A1 (en) * 2017-08-09 2020-06-17 Albireo AB Cholestyramine pellets, oral cholestyramine formulations and use thereof
TW202015699A (en) 2018-06-05 2020-05-01 瑞典商艾爾比瑞歐公司 Benzothia(di)azepine compounds and their use as bile acid modulators
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
WO2019245449A1 (en) 2018-06-20 2019-12-26 Albireo Ab Pharmaceutical formulation of odevixibat
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
EP4069361B1 (en) 2019-12-04 2024-01-03 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
JP2023504647A (en) 2019-12-04 2023-02-06 アルビレオ・アクチボラグ Benzothia(di)azepine compounds and their use as bile acid modulators
EP4069247A1 (en) 2019-12-04 2022-10-12 Albireo AB Benzothiadiazepine compounds and their use as bile acid modulators
FI4069360T3 (en) 2019-12-04 2024-02-20 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
CN116157389A (en) 2020-08-03 2023-05-23 阿尔比里奥公司 Benzothiazepine compounds and their use as bile acid modulators
CA3196488A1 (en) 2020-11-12 2022-05-19 Albireo Ab Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
JP2024500309A (en) 2020-12-04 2024-01-09 アルビレオ エービー Benzothia(di)azepine compounds and their use as bile acid modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1348642A (en) * 1970-10-15 1974-03-20 Howard A N Hypocholesterolaemic compositions
GB1566609A (en) 1977-03-10 1980-05-08 Reckitt & Colmann Prod Ltd Pharmaceutical compositions containing cholestyramine and alginic acid
DE3572440D1 (en) 1984-06-19 1989-09-28 Basf Ag Gastro-resistant cylindrical pancreatine-microtablets
ZA876640B (en) 1986-09-26 1988-03-08 Warner-Lambert Company Treated lipid regulator
US4814354A (en) 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
CA1313135C (en) * 1987-02-09 1993-01-26 The Dow Chemical Company Cholestyramine composition and process for its preparation
EP0323666B1 (en) * 1987-12-29 1992-03-25 The Procter & Gamble Company Mixed compositions for treating hypercholesterolemia
DE3808191C2 (en) 1988-03-11 1998-08-06 Astra Chem Gmbh Pharmaceutical composition containing colestyramine
US4931280A (en) 1988-06-13 1990-06-05 Basf K & F Corporation Edible, baked compositions containing cholestyramine

Also Published As

Publication number Publication date
AU638493B2 (en) 1993-07-01
ATE125448T1 (en) 1995-08-15
CA2065151A1 (en) 1991-03-10
JPH05500213A (en) 1993-01-21
IL95574A (en) 1994-11-11
IL95574A0 (en) 1991-06-30
EP0594570B1 (en) 1995-07-26
KR920703071A (en) 1992-12-17
DK0594570T3 (en) 1995-09-11
EP0594570A1 (en) 1994-05-04
WO1991003249A1 (en) 1991-03-21
DE59009451D1 (en) 1995-08-31

Similar Documents

Publication Publication Date Title
AU6405790A (en) Preparations containing colestyramine for reducing lipid levels
AU3789089A (en) Multi-specimen slides for immunohistologic procedures
AU1277288A (en) Leakage detector
AU5220190A (en) Preservative system for ophthalmic formulations
AU4473889A (en) Translation technique
AU4474189A (en) Translation technique
AU1281688A (en) Deodorizing apparatus
AU5866390A (en) Power source means
AU7257791A (en) Uv lamp enclosure sleeve
AU5285690A (en) Backflash interrupter
AU5003690A (en) Peroxide for sterilization
AU630500B2 (en) Implanter
AU617995B2 (en) Esperamicin derivatives
AU7358591A (en) Lipopeptide derivatives
AU6881691A (en) Instrument for anastomosis
AU1097988A (en) Alkylmelatonins
AU4857490A (en) Eyeball assembly for an eyeball fitting
AU6328590A (en) Amplifier arrangement
AU1157688A (en) Projector apparatus
AU630680B2 (en) Color-former
AU2046388A (en) Multi-bulb light source
AU5546090A (en) Antibody-lactate oxidase conjugates
AU5828990A (en) Beeper amplifier
HU913573D0 (en) Complexes containing s(+)alkaneacids and alpha-hydroxy-alkaneacids
GR3005231T3 (en)

Legal Events

Date Code Title Description
PC Assignment registered

Owner name: NORDMARK ARZNEIMITTEL GMBH AND CO KG

Free format text: FORMER OWNER WAS: KNOLL AKTIENGESELLSCHAFT